Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | APP | P05067 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.36 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15859157 | 0.86 | MAPT (0.72) | MAPTAPPALDH1A1KMT2AHPGD | |
| SCHEMBL14730380 | 0.86 | MAPT (0.72) | MAPTAPPALDH1A1KMT2AHPGD | |
| SCHEMBL15859154 | 0.86 | MAPT (0.72) | MAPTAPPALDH1A1KMT2AHPGD | |
| SCHEMBL21037329 | 0.86 | MAPT (0.48) | MAPTAPPALDH1A1KMT2AHPGD | |
| SCHEMBL21160414 | 0.84 | MAPT (0.52) | MAPTAPPALDH1A1KMT2AHPGD | |
| SCHEMBL437080 | 0.83 | MAPT (0.71) | MAPTAPPALDH1A1KMT2ATDP1 | |
| SCHEMBL21036835 | 0.82 | LMNA (0.50) | MAPTAPPALDH1A1KMT2AHPGD | |
| SCHEMBL11936998 | 0.82 | MAPT (0.77) | MAPTAPPALDH1A1KMT2AHPGD | |
| SCHEMBL3437234 | 0.82 | MAPT (0.77) | MAPTAPPALDH1A1KMT2AHPGD | |
| SCHEMBL15859159 | 0.81 | MAPT (0.66) | MAPTAPPALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY (CN) | 2021-12-28 | — | — | US | disclosed |
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | HNRNPF, HNRNPUL2, RAB5IF | MAPT 2624/4885APP 2001/4885ALDH1A1 3152/4885 |
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | HNRNPF, HNRNPUL2, RAB5IF | MAPT 2624/4885APP 2001/4885ALDH1A1 3152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.